Showing posts from December, 2023

Auckland Blaze Leads to Closure of School Due to Asbestos Hazard

Mountain View School in Māngere Bridge had to close its doors after a substantial fire that took place on Thursday morning. The fire, which involved multiple houses on Coronation Road, prompted the closure of the school due to concerns about potential asbestos exposure resulting from the burning buildings. Fire and Emergency New Zealand received numerous calls about multiple houses engulfed in flames on Coronation Road at around 2:58 am. A firefighter on-site mentioned that the fire affected five structures, including an older building where asbestos exposure might be a risk due to its age. Public health officials from Te Whatu Ora were evaluating the asbestos risk to the local community following the fire's extinguishment. They highlighted the possibility of asbestos release into the air due to the age of the destroyed buildings. Do You Actually Require Asbestos Air Quality Testing Auckland Blaze Leads to Closure of School Due to Asbestos Hazard Efforts were underway to cond

Workplace Fatality: Quedgeley Individual Succumbs to Asbestos Exposure

A coroner determined that a man's passing was directly attributed to prolonged exposure to hazardous asbestos over his 32-year professional tenure.   As per a report published in BBC , David Mills, of The Causeway in Quedgeley, was diagnosed with asbestos-related lung cancer in 2020. He reported regularly coming into contact with the fibrous material at Royal Mail post office sites while working as an electrician. A coroner ruled his cause of death was "industrial disease" after he passed away on 30 November this year, aged 71. Mr Mills first began working for South West Post (later taken over by Romec Ltd) in 1979 and his duties included electrical maintenance and installation. Many Royal Mail sites where he worked, including Tewkesbury, Ross on Wye and Gloucester, were undergoing refits at the time and asbestos was present in ceiling and roof tiles, panels and fuse boxes. In a statement made by Mr Mills in which he took civil action against his former employers, he expl

Sarcomatoid Mesothelioma Treatment, Diagnosis Survival and Sub types

Sarcomatoid Mesothelioma- Do you know why Sarcomatoid mesothelioma happens to be one of the most dreaded forms of mesothelioma? Well, there are a number of reasons to explain this. But first, we would like to update you something more about this kind of mesothelioma cancer that you should know about it.  We would also let you know about the line of treatment and   other diagnosis options that you have after your doctor confirms about it.Telling you in terms of numbers. Please note that Sarcomatoid mesothelioma is a lesser known mesothelioma as it has the least known cell structure. Not only that, most patients have poor prognosis just because of the fact that this type of mesothelioma cancer progresses very fast and therefore becomes quite difficult to treat. Telling you in the percentage of cases, please know that sarcomatoid mesothelioma is quite a rare type of mesothelioma that generally comprises only 10-20% of all mesothelioma cases. Furthermore, this kin

Sealord Neglects Responsibility for Staff Exposed to Asbestos In New Zealand

A hefty bill has been sent to a major fishing company after it exposed its staff to asbestos .  Sealord, one of the largest fishing companies in the Southern Hemisphere, was ordered to pay two victims $3000 each in reparation, fined $257,250, and ordered to pay $28,987 in costs to Maritime NZ, in the Nelson District Court on Tuesday. Maritime NZ had investigated after asbestos was found on board the Will Watch, a Cook Islands-flagged ship owned by Sealord’s overseas subsidiary United Fame Investments. Aotearoa-based employees were seconded to work on the ship in Mauritius. Maritime NZ’s general manager investigations Pete Dwen said the workers were still subject to the terms and conditions of their employment agreement with Sealord, which made Sealord responsible for the safety of its workers. Senior staff members of Sealord had monitored the vessel’s health and safety operations and gave input on operating procedures, which should have identified the issues with the asbestos. H

A Mesothelioma Patient Attributes His Illness to Asbestos In DAP Products

Jose Munoz, before succumbing to malignant mesothelioma , provided testimony implicating companies he held responsible for his asbestos exposure .  He specifically recounted his work involving DAP, Inc. caulks and plaster products, highlighting the dust he inhaled while sanding down these materials. While DAP insisted on dismissing the case, contending that their products were asbestos-free, the judge overseeing the matter dismissed their request. The judge cited DAP's failure to meet the legal standard required to warrant dismissal, thus allowing the case to proceed.   Legal Mandate Demands Asbestos Company Prove Their Product Couldn't Have Caused Mesothelioma Fatality In a mesothelioma lawsuit, a defendant company has the right to request the dismissal of the case. However, they must provide substantial evidence to support this request in accordance with legal requirements. This mandate entails presenting evidence that resolves significant factual discrepancies with

Expected Growth of Malignant Mesothelioma Market to Reach $1,347.15 Million by 2030, with an 8.21% CAGR: A Report By 360iResearch

Image has included the " Malignant Mesothelioma Market" report in its offerings. This report forecasts the global market to grow from USD 716.10 million in 2022 to USD 1,347.15 million by 2030, at a CAGR of 8.21% .   FPNV Positioning Matrix: The FPNV Positioning Matrix assesses vendors based on Business Strategy and Product Satisfaction metrics, grouping them into four quadrants: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). This analysis helps users make informed decisions tailored to their needs.   Market Share Analysis: This analysis provides insights into vendor performance, including revenue, customer base, and other metrics, offering a competitive landscape view. It outlines market competitiveness, fragmentation, and dominance during the study period.   Key Company Profiles: The report highlights significant developments in the Malignant Mesothelioma Market, featuring leading vendors like AbbVie Inc., Advanz Pharma Corp., Argenx SE,